chr14-23415801-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP2PP3
The ENST00000355349.4(MYH7):c.4985G>A(p.Arg1662His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1662C) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000355349.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH7 | NM_000257.4 | c.4985G>A | p.Arg1662His | missense_variant | 35/40 | ENST00000355349.4 | NP_000248.2 | |
MHRT | NR_126491.1 | n.233C>T | non_coding_transcript_exon_variant | 2/6 | ||||
MYH7 | NM_001407004.1 | c.4985G>A | p.Arg1662His | missense_variant | 34/39 | NP_001393933.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH7 | ENST00000355349.4 | c.4985G>A | p.Arg1662His | missense_variant | 35/40 | 1 | NM_000257.4 | ENSP00000347507 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251418Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135904
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461894Hom.: 0 Cov.: 34 AF XY: 0.0000358 AC XY: 26AN XY: 727248
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74348
ClinVar
Submissions by phenotype
Cardiomyopathy Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Aug 08, 2023 | This missense variant replaces arginine with histidine at codon 1662 of the MYH7 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in four individuals affected with hypertrophic cardiomyopathy (PMID: 23233322, 27532257, 31638223, 34137518, 33495597). However, one of these individuals also harbored a splice site variant in the MYBPC3 gene that was associated with disease in the family (PMID: 23233322), and another individual is a carrier of a pathogenic co-variant MYH7 c.2081G>A (p.Arg694His) (ClinVar Variation ID: 264068). This variant has also been reported in one individual affected with dilated cardiomyopathy (PMID: 21750094). This variant has been identified in 16/282816 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | May 04, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Feb 23, 2023 | This missense variant replaces arginine with histidine at codon 1662 of the MYH7 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in four individuals affected with hypertrophic cardiomyopathy (PMID: 23233322, 27532257, 31638223, 34137518, 33495597). However, one of these individuals also harbored a splice site variant in the MYBPC3 gene that was associated with disease in the family (PMID: 23233322), and another individual is a carrier of a pathogenic co-variant MYH7 c.2081G>A (p.Arg694His) (ClinVar Variation ID: 264068). This variant has also been reported in one individual affected with dilated cardiomyopathy (PMID: 21750094). This variant has been identified in 16/282816 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Hypertrophic cardiomyopathy Uncertain:2
Uncertain significance, criteria provided, single submitter | research | Genetics and Genomics Program, Sidra Medicine | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 19, 2022 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1662 of the MYH7 protein (p.Arg1662His). This variant is present in population databases (rs370328209, gnomAD 0.03%). This missense change has been observed in individual(s) with dilated cardiomyopathy or hypertrophic cardiomyopathy (PMID: 21750094, 23233322, 27532257, 31638223). ClinVar contains an entry for this variant (Variation ID: 43049). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYH7 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 08, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 20, 2018 | This variant is associated with the following publications: (PMID: 25637381, 23299917, 23233322, 22958901, 21750094, 27532257, 31638223) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 12, 2019 | The p.Arg1662His variant in MYH7 has been reported in 4 individuals with cardiomyopathy (2 with DCM and 2 with HCM) and did not segeregate with disease in an affected relative in one of the families with HCM (Waldmuller 2011, Kassem 2013, Walsh 2017, LMM data). It has been identified in 0.03% (3/10368) of Ashkenazi Jewish chromosomes and 8/129130 European chromosomes gnomAD (http://gnomad.broadinstitute.org). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PP3. - |
Primary dilated cardiomyopathy Uncertain:1
Uncertain significance, no assertion criteria provided | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 21, 2022 | The c.4985G>A (p.R1662H) alteration is located in exon 35 (coding exon 33) of the MYH7 gene. This alteration results from a G to A substitution at nucleotide position 4985, causing the arginine (R) at amino acid position 1662 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at